Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans

Cancer Epidemiology

Volumn 35, Issue 4, 2011, Pages 320-327

  Gunderson, Kristin ^a   Wang, Christopher Y ^a   Wang, Ruoxiang ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Admixture; African; African American; Northern European; Prostate cancer incidence

Indexed keywords

AFRICA; AFRICAN AMERICAN; ARTICLE; AUSTRALIA; CANADA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; ETHNICITY; EUROPE; GENETIC SUSCEPTIBILITY; HUMAN; MIGRATION; NEW ZEALAND; PRIORITY JOURNAL; PROSTATE CANCER; REFUGEE; SCANDINAVIA; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; EMIGRATION AND IMMIGRATION; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISTORY, MEDIEVAL; HUMANS; INCIDENCE; MALE; MOLECULAR EPIDEMIOLOGY; PROSTATIC NEOPLASMS;

EID: 79960610091     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.11.007     Document Type: Article

References (61)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., et al. Human prostate cancer risk factors. Cancer 2004, 101:2371-2490.
3. Langeberg W.J., Isaacs W.B., Stanford J.L. Genetic etiology of hereditary prostate cancer. Front Biosci 2007, 12:4101-4110.
4. Gronberg H., Damber L., Damber J.E. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994, 152:1484-1487. [Discussion 1487-1489].
5. Page W.F., Braun M.M., Partin A.W., Caporaso N., Walsh P. Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997, 33:240-245.
6. Ahlbom A., Lichtenstein P., Malmstrom H., Feychting M., Hemminki K., Pedersen N.L. Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997, 89:287-293.
7. Schaid D.J., McDonnell S.K., Blute M.L., Thibodeau S.N. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998, 62:1425-1438.
8. Valeri A., Briollais L., Azzouzi R., Fournier G., Mangin P., Berthon P., et al. Segregation analysis of prostate cancer in France: evidence for autosomal dominant inheritance and residual brother-brother dependence. Ann Hum Genet 2003, 67:125-137.
9. Carter B.S., Steinberg G.D., Beaty T.H., Childs B., Walsh P.C. Familial risk factors for prostate cancer. Cancer Surv 1991, 11:5-13.
10. Gronberg H., Damber L., Damber J.E., Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997, 146:552-557.
11. Pakkanen S., Baffoe-Bonnie A.B., Matikainen M.P., Koivisto P.A., Tammela T.L., Deshmukh S., et al. Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet 2007, 121:257-267.
12. Freedman M.L., Haiman C.A., Patterson N., McDonald G.J., Tandon A., Waliszewska A., et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 2006, 103:14068-14073.
13. Amundadottir L.T., Sulem P., Gudmundsson J., Helgason A., Baker A., Agnarsson B.A., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006, 38:652-658.
14. Suuriniemi M., Agalliu I., Schaid D.J., Johanneson B., McDonnell S.K., Iwasaki L., et al. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007, 16:809-814.
15. Xu J., Dimitrov L., Chang B.L., Adams T.S., Turner A.R., Meyers D.A., et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005, 77:219-229.
16. Chang B.L., Lange E.M., Dimitrov L., Valis C.J., Gillanders E.M., Lange L.A., et al. Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect. Hum Genet 2006, 118:716-724.
17. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., Mugerwa J.W. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 1993, 54:26-36.
18. Cussenot O., Valeri A. Heterogeneity in genetic susceptibility to prostate cancer. Eur J Intern Med 2001, 12:11-16.
19. Ogunbiyi J.O., Shittu O.B. Increased incidence of prostate cancer in Nigerians. J Natl Med Assoc 1999, 91:159-164.
20. Walker A.R., Walker B.F. Puzzles in the causation and epidemiology of prostate cancer-a sombre outlook. S Afr Med J 2003, 93:773-774.
21. Wadee A.A., Kuschke R., Botha Y., Jamieson G.A., Walker A.R., Kakembo A.S., et al. Low serum prostate-specific antigen levels in elderly rural African men at very low risk of prostate cancer. Eur J Cancer Prev 2002, 11:63-65.
22. Walker A.R. Prostate cancer-some aspects of epidemiology, risk factors, treatment and survival. S Afr Med J 1986, 69:44-47.
23. Burack T.S., Burack W.R., Knowlden N.F. Cancer II. Distortions in standardized rates. J Occup Med 1983, 25:737-744.
24. Anderson R.N., Rosenberg H.M. Report of the second workshop on age adjustment. Vital Health Stat 1998, 4(I-VI):1-37.
25. Sandblom G., Dufmats M., Olsson M., Varenhorst E. Validity of a population-based cancer register in Sweden-an assessment of data reproducibility in the South-East Region Prostate Cancer Register. Scand J Urol Nephrol 2003, 37:112-119.
26. Higgins P.B., Fernandez J.R., Goran M.I., Gower B.A. Early ethnic difference in insulin-like growth factor-1 is associated with African genetic admixture. Pediatr Res 2005, 58:850-854.
27. Gilbert F., Schoelkopf J., Li Z., Arzimanoglou I.I., Shaham M., Udey J., et al. Ethnic intermarriage and its consequences for cystic fibrosis carrier screening. Am J Prev Med 1995, 11:251-255.
28. Acton R.T., Barton J.C., Bell D.S., Go R.C., Roseman J.M. HFE mutations in African-American women with non-insulin-dependent diabetes mellitus. Ethn Dis 2001, 11:578-584.
29. Restrepo C.M., Pineda L., Rojas-Martinez A., Gutierrez C.A., Morales A., Gomez Y., et al. CFTR mutations in three Latin American countries. Am J Med Genet 2000, 91:277-279.
30. Condon J.R., Armstrong B.K., Barnes T., Zhao Y. Cancer incidence and survival for indigenous Australians in the Northern Territory. Aust N Z J Public Health 2005, 29:123-128.
31. Gleize L., Laudon F., Sun L.Y., Challeton-de Vathaire C., Le Vu B., de Vathaire F. Cancer registry of French Polynesia: results for the 1990-1995 period among native and immigrant population. Eur J Epidemiol 2000, 16:661-667.
32. Lanier A.P., Bulkow L.R., Ireland B. Cancer in Alaskan Indians, Eskimos, and Aleuts, 1969-83: implications for etiology and control. Public Health Rep 1989, 104:658-664.
33. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
34. Bah E., Parkin D.M., Hall A.J., Jack A.D., Whittle H. Cancer in the Gambia: 1988-97. Br J Cancer 2001, 84:1207-1214.
35. Jackson M.A., Ahluwalia B.S., Attah E.B., Connolly C.A., Herson J., Heshmat M.Y., et al. Characterization of prostatic carcinoma among blacks: a preliminary report. Cancer Chemother Rep 1975, 59:3-15.
36. Koulibaly M., Kabba I.S., Cisse A., Diallo S.B., Diallo M.B., Keita N., et al. Cancer incidence in Conakry, Guinea: first results from the Cancer Registry 1992-1995. Int J Cancer 1997, 70:39-45.
37. Ogunlewe J.O., Osegbe D.N. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 1989, 63:1388-1392.
38. Walker A.R., Walker B.F., Segal I. Cancer patterns in three African populations compared with the United States black population. Eur J Cancer Prev 1993, 2:313-320.
39. Walker A.R., Walker B.F., Tsotetsi N.G., Sebitso C., Siwedi D., Walker A.J. Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 1992, 65:438-441.
40. Odedina F.T., Ogunbiyi J.O., Ukoli F.A. Roots of prostate cancer in African-American men. J Natl Med Assoc 2006, 98:539-543.
41. Angwafo F.F., Yomi J., Mbakop A. Is cancer of the prostate rare in tropical (black) Africa? Case series from the Centre Hospitalier et Universitaire and the Hospital General de Yaounde from 1986 to 1990. Bull Cancer Radiother 1994, 81:155-159.
42. Osegbe D.N. Prostate cancer in Nigerians: facts and nonfacts. J Urol 1997, 157:1340-1343.
43. Wabinga H.R., Parkin D.M., Wabwire-Mangen F., Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000, 82:1585-1592.
44. Wiredu E.K., Armah H.B. Cancer mortality patterns in Ghana: a 10-year review of autopsies and hospital mortality. BMC Public Health 2006, 6:159.
45. Cavalli-Sforza L.L., Menozzi P., Piazza A. The history and geography of human genes 1994, Princeton University Press, Princeton, NJ.
46. Lind J.M., Hutcheson-Dilks H.B., Williams S.M., Moore J.H., Essex M., Ruiz-Pesini E., et al. Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet 2007, 120:713-722.
47. Sans M., Weimer T.A., Franco M.H., Salzano F.M., Bentancor N., Alvarez I., et al. Unequal contributions of male and female gene pools from parental populations in the African descendants of the city of Melo, Uruguay. Am J Phys Anthropol 2002, 118:33-44.
48. Rybicki B.A., Iyengar S.K., Harris T., Liptak R., Elston R.C., Sheffer R., et al. The distribution of long range admixture linkage disequilibrium in an African-American population. Hum Hered 2002, 53:187-196.
49. Cabello G.M., Moreira A.F., Horovitz D., Correia P., Santa Rosa A., Llerena J., et al. Cystic fibrosis: low frequency of DF508 mutation in 2 population samples from Rio de Janeiro, Brazil. Hum Biol 1999, 71:189-196.
50. Pereira A.C., Mota G.F., Krieger J.E. Hemochromatosis gene variants in three different ethnic populations: effects of admixture for screening programs. Hum Biol 2001, 73:145-151.
51. Vizzi E., Loureiro C.L., Gerder M., de las Nieves Garcia-Casal M., Rodriguez-Larralde A., Gerace L., et al. Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample. Ann Hematol 2005, 84:802-806.
52. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci 2004, 1028:1-13.
53. Campisi J. Aging, tumor suppression and cancer: high wire-act!. Mech Ageing Dev 2005, 126:51-58.
54. Troen B.R. The biology of aging. Mt Sinai J Med 2003, 70:3-22.
55. Weinstein B.S., Ciszek D. The reserve-capacity hypothesis: evolutionary origins and modern implications of the trade-off between tumor-suppression and tissue-repair. Exp Gerontol 2002, 37:615-627.
56. Knight J.C. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005, 83:97-109.
57. Wang X., Tomso D.J., Liu X., Bell D.A. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol 2005, 207:84-90.
58. Gerstein M.B., Bruce C., Rozowsky J.S., Zheng D., Du J., Korbel J.O., et al. What is a gene, post-ENCODE? History and updated definition. Genome Res 2007, 17:669-681.
59. Gingeras T.R. Origin of phenotypes: genes and transcripts. Genome Res 2007, 17:682-690.
60. Seldin M.F., Morii T., Collins-Schramm H.E., Chima B., Kittles R., Criswell L.A., et al. Putative ancestral origins of chromosomal segments in individual african americans: implications for admixture mapping. Genome Res 2004, 14:1076-1084.
61. Smith M.W., O'Brien S.J. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet 2005, 6:623-632.